In this issue:
Ultrasound vs abbreviated MRI for HCC screening in NAFLD cirrhosis
Risk of HCC with tenofovir vs entecavir
Long-term renal safety of tenofovir vs entecavir
Pregnancies with cirrhosis and maternal and perinatal outcomes
Risk of hepatic and extrahepatic cancer in NAFLD
Development of the AI-Cirrhosis-ECG score
Fibrosis-4 index and MACE in NAFLD
Prediction of short-term mortality in alcohol-associated hepatitis
Predictors of liver transplantation or death in drug-induced acute liver failure
BMS-986263 for advanced hepatic fibrosis
Please login below to download this issue (PDF)